poly(A)-vazebný protein II [Poly(A)-Binding Protein II]
- Termíny
-
PAB II
PAB2 Poly(A) Binding Protein
PABP2
Pabp2 Gene Product
Pabp2 Protein
Poly(A) Binding Protein II
Poly(A) Binding Protein, Nuclear 1
A poly(A) binding protein that is involved in promoting the extension of the poly A tails of MRNA. The protein requires a minimum of ten ADENOSINE nucleotides in order for binding to mRNA. Once bound it works in conjunction with CLEAVAGE AND POLYADENYLATION SPECIFICITY FACTOR to stimulate the rate of poly A synthesis by POLY A POLYMERASE. Once poly-A tails reach around 250 nucleotides in length poly(A) binding protein II no longer stimulates POLYADENYLATION. Mutations within a GCG repeat region in the gene for poly(A) binding protein II have been shown to cause the disease MUSCULAR DYSTROPHY, OCULOPHARYNGEAL.
- DUI
- D039103 MeSH Prohlížeč
- CUI
- M0103425
- Předchozí užití
- RNA-Binding Proteins (1995-2002)
- Historická pozn.
- 2003; for PAB II use POLY(A)-BINDING PROTEINS (NM) 1995-2002; for PABP2 GENE PRODUCT & PABP2 PROTEIN use POLY(A)-BINDING PROTEINS (NM) 1999-2002; for PABP2 use POLY(A)-BINDING PROTEINS (NM) 2000-2002
- Veřejná pozn.
- 2003; PAB II was indexed under RNA-BINDING PROTEINS 1995-2002; PABP2 GENE PRODUCT & PABP2 PROTEIN were indexed under RNA-BINDING PROTEINS 1999-2002; PABP2 was indexed under RNA-BINDING PROTEINS 2000-2002
Povolená podhesla
- AG
- agonisté
- AN
- analýza
- AI
- antagonisté a inhibitory
- AD
- aplikace a dávkování
- BI
- biosyntéza
- CS
- chemická syntéza
- CH
- chemie
- HI
- dějiny
- EC
- ekonomika
- PK
- farmakokinetika
- PD
- farmakologie
- PH
- fyziologie
- GE
- genetika
- IM
- imunologie
- IP
- izolace a purifikace
- CL
- klasifikace
- BL
- krev
- ME
- metabolismus
- UR
- moč
- CF
- mozkomíšní mok
- DF
- nedostatek
- ST
- normy
- PO
- otrava
- AE
- škodlivé účinky
- TU
- terapeutické užití
- TO
- toxicita
- DE
- účinky léků
- RE
- účinky záření
- UL
- ultrastruktura
- SD
- zásobování a distribuce